Cognitive Outcomes at Age 3 Years in Children With Fetal Exposure to Antiseizure Medications in the US
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study
Lancet Neurol 2023 Aug 01;22(8)712-722, KJ Meador, MJ Cohen, DW Loring, AG Matthews, C Brown, CP Robalino, AK Birnbaum, PE Voinescu, LA Kalayjian, EE Gerard, ER Gedzelman, J Hanna, J Cavitt, M Sam, JA French, S Hwang, AM Pack, PB PennellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.